CRLBF (Cresco Labs) Cyclically Adjusted PB Ratio: (As of Sep. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CRLBF Cresco Labs Inc CRLBF
29 GF Score
Price $0.74
GF Value $0.87
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Cresco Labs Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cresco Labs  (OTCPK:CRLBF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cresco Labs Cyclically Adjusted PB Ratio Related Terms


Cresco Labs Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Cresco Labs's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cresco Labs Cyclically Adjusted PB Ratio Chart

Cresco Labs Annual Data
Trend Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cresco Labs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CRLBF vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Cyclically Adjusted PB Ratio falls into.


CRLBF
29GF Score
Cresco Labs Inc CRLBF
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cresco Labs Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cresco Labs's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Cresco Labs's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.963/333.9520*333.9520
=0.963

Current CPI (Jun. 2026) = 333.9520.

Cresco Labs Quarterly Data

Book Value per Share CPI Adj_Book
201607 -24.257 240.628 -33.665
201610 -23.829 241.729 -32.920
201701 -26.314 242.839 -36.187
201704 -25.657 244.524 -35.040
201707 -28.571 244.786 -38.978
201710 -28.114 246.663 -38.063
201801 -30.400 247.867 -40.958
201804 -29.800 250.546 -39.720
201807 -26.086 252.006 -34.569
201810 -0.243 252.885 -0.321
201903 1.077 254.202 1.415
201906 1.029 256.143 1.342
201909 1.329 256.759 1.729
201912 1.422 256.974 1.848
202003 3.033 258.115 3.924
202006 2.871 257.797 3.719
202009 2.823 260.280 3.622
202012 2.118 260.474 2.715
202103 2.520 264.877 3.177
202106 3.299 271.696 4.055
202109 2.447 274.310 2.979
202112 2.599 278.802 3.113
202203 2.479 287.504 2.879
202206 2.675 296.311 3.015
202209 2.622 296.808 2.950
202212 2.082 296.797 2.343
202303 2.012 301.836 2.226
202306 1.854 305.109 2.029
202309 1.500 307.789 1.628
202312 1.489 306.746 1.621
202403 1.471 312.332 1.573
202406 1.345 314.175 1.430
202409 1.314 315.301 1.392
202412 1.362 315.605 1.441
202503 1.310 319.799 1.368
202506 1.251 322.561 1.295
202509 1.198 324.800 1.232
202512 0.947 324.054 0.976
202603 0.907 330.213 0.917
202606 0.963 333.952 0.963

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Cresco Labs (CRLBF) Overvalued in 2026?

Based on GuruFocus' analysis, Cresco Labs stock appears to be undervalued. The current stock price of $0.74 is trading 14.8% below its estimated GF Value™ of $0.87. GuruFocus considers Cresco Labs to be Modestly Undervalued.

Key valuation signals for CRLBF:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $0.87 vs. price of $0.74 (14.8% below fair value)
  • GF Score™: 29/100 with 6 warning signs

No single metric tells the full story. See the CRLBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cresco Labs Business Description

Other Exchanges 6CQ:GermanyCL:Canada
Address 600 W. Fulton Street, Suite 800, Chicago, IL, USA, 60661
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
29GF Score

Get the complete analysis for CRLBF

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.74
Price
$0.87
GF Value